Communication: High-Density Lipoprotein-Specific fi c Phospholipid Efflux ffl ux in Familial Hypercholesterolemia

被引:0
|
作者
Sato, Masaki [1 ,2 ]
Hamasaki, Masato [1 ,2 ]
Neufeld, Edward B. [3 ]
Remaley, Alan T. [3 ,4 ]
Kotani, Kazuhiko [1 ]
机构
[1] Jichi Med Univ, Div Community & Family Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan
[2] Eiken Chem Co Ltd, Biochem Res Lab, Nogi, Tochigi, Japan
[3] NHLBI, Lipoprotein Metab Lab, NIH, Bethesda, MD USA
[4] NIH, NIH Clin Ctr, Bethesda, MD USA
来源
关键词
apolipoprotein A-I; cardiovascular disease; cholesterol efflux capacity; hypercholesterolemia; high-density lipoprotein; phospholipid efflux; APOLIPOPROTEIN-A-I; HDL; ABNORMALITIES;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective. Familial hypercholesterolemia (FH) is characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C) and cardiovascular disease (CVD). Although the role of LDL-C in FH has been studied, the contribution of high-density lipoproteins (HDL) to CVD in FH remains unknown. This study aimed at highlighting the role of HDL in FH. Methods. HDL-specific phospholipid efflux (HDL-SPE) assay was developed to predict CVD risk. HDL-SPE was examined in FH patients (n=30) and compared with age- and sex-matched non-FH controls (n=60). Results. FH patients had significantly lower HDL-SPE levels (0.90 +/- 0.12) than controls (1.12 +/- 0.10; p<0.05), despite similar HDL-cholesterol levels in after adjusting for confounders. Conclusions. These findings suggest there may be dysfunctionality of HDL in FH.
引用
收藏
页码:419 / 422
页数:4
相关论文
共 35 条
  • [1] Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease
    Sato, Masaki
    Neufeld, Edward B.
    Playford, Martin P.
    Lei, Yu
    Sorokin, Alexander V.
    Aponte, Angel M.
    Freeman, Lita A.
    Gordon, Scott M.
    Dey, Amit K.
    Jeiran, Kianoush
    Hamasaki, Masato
    Sampson, Maureen L.
    Shamburek, Robert D.
    Tang, Jingrong
    Chen, Marcus Y.
    Kotani, Kazuhiko
    Anderson, Josephine L. C.
    Dullaart, Robin P. F.
    Mehta, Nehal N.
    Tietge, Uwe J. F.
    Remaley, Alan T.
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (18):
  • [2] Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency
    Marcil, M
    Bissonnette, R
    Vincent, J
    Krimbou, L
    Genest, J
    CIRCULATION, 2003, 107 (10) : 1366 - 1371
  • [3] ABNORMALITIES IN SERUM HIGH-DENSITY LIPOPROTEIN LEVELS AND DISTRIBUTION IN FAMILIAL HYPERCHOLESTEROLEMIA
    GOLDBERG, RB
    FLESS, GM
    SCANU, AM
    GETZ, GS
    SEFTEL, HC
    MENDELSSOHN, D
    RUBENSTEIN, AH
    CLINICAL RESEARCH, 1980, 28 (02): : A556 - A556
  • [4] VASCULAR BIOLOGY I. HIGH-DENSITY LIPOPROTEIN PHOSPHOLIPID CONTENT AND APOLIPOPROTEIN A-I LEVEL ARE DETERMINANTS OF CHOLESTEROL EFFLUX CAPACITY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA
    Ogura, M.
    Harada-Shiba, M.
    ATHEROSCLEROSIS, 2016, 252 : E199 - E199
  • [5] Transfer of lipids to high-density lipoprotein (HDL) is altered in patients with familial hypercholesterolemia
    Martinez, Lilton R. C.
    Santos, Raul D.
    Miname, Marcio H.
    Deus, Debora F.
    Lima, Emerson S.
    Maranhao, Raul C.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (08): : 1061 - 1064
  • [6] Is High-Density Lipoprotein Functionality Useful as a Residual Risk Marker for Familial Hypercholesterolemia?
    Ogura, Masatsune
    CIRCULATION JOURNAL, 2023, 87 (06) : 813 - 814
  • [7] Impact of High-Density Lipoprotein Function, Rather Than High-Density Lipoprotein Cholesterol Level, on Cardiovascular Disease Among Patients With Familial Hypercholesterolemia
    Tada, Hayato
    Okada, Hirofumi
    Nohara, Atsushi
    Toh, Ryuji
    Harada, Amane
    Murakami, Katsuhiro
    Iino, Takuya
    Nagao, Manabu
    Ishida, Tatsuro
    Hirata, Ken-ichi
    Takamura, Masayuki
    Kawashiri, Masa-aki
    CIRCULATION JOURNAL, 2023, 87 (06) : 806 - +
  • [8] Paraoxonase genotype and phenotype contribute to plasma high-density lipoprotein levels in familial hypercholesterolemia
    van Himbergen, T
    Roest, M
    de Graaf, J
    Voorbij, R
    van Tits, L
    Stalenhoef, A
    CIRCULATION, 2003, 108 (17) : 200 - 201
  • [9] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, SMOKING, AND ISCHEMIC HEART-DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA
    GAGNE, C
    MOORJANI, S
    BRUN, D
    LUPIEN, PJ
    ARTERIOSCLEROSIS, 1989, 9 (05): : A734 - A734
  • [10] High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia
    Wierzbicki, AS
    Lumb, PJ
    Chik, G
    Crook, MA
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (05): : 547 - +